These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 7609919)
1. Possible involvement of vasoactive intestinal polypeptide in the central stimulating action of pituitary adenylate cyclase-activating polypeptide on prolactin secretion in the rat. Yamauchi K; Murakami Y; Nishiki M; Tanaka J; Koshimura K; Kato Y Neurosci Lett; 1995 Apr; 189(2):131-4. PubMed ID: 7609919 [TBL] [Abstract][Full Text] [Related]
2. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion. Huang SK; Pan JT Neuroendocrinology; 1996 Sep; 64(3):208-14. PubMed ID: 8875438 [TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss. Montpetit CJ; Perry SF J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664 [TBL] [Abstract][Full Text] [Related]
4. Central effects of pituitary adenylate cyclase activating polypeptide (PACAP) on gastric motility and emptying in rats. Ozawa M; Aono M; Moriga M Dig Dis Sci; 1999 Apr; 44(4):735-43. PubMed ID: 10219831 [TBL] [Abstract][Full Text] [Related]
6. Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP. Bredow S; Kacsóh B; Obál F; Fang J; Krueger JM Brain Res; 1994 Oct; 660(2):301-8. PubMed ID: 7820699 [TBL] [Abstract][Full Text] [Related]
7. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro. Sawangjaroen K; Anderson ST; Curlewis JD J Neuroendocrinol; 1997 Apr; 9(4):279-86. PubMed ID: 9147291 [TBL] [Abstract][Full Text] [Related]
8. Effect of pituitary adenylate cyclase-activating polypeptide 38 on growth hormone and prolactin expression. Velkeniers B; Zheng L; Kazemzadeh M; Robberecht P; Vanhaelst L; Hooghe-Peters EL J Endocrinol; 1994 Oct; 143(1):1-11. PubMed ID: 7964308 [TBL] [Abstract][Full Text] [Related]
9. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on prolactin, luteinizing hormone and growth hormone secretion in the ewe. Sawangjaroen K; Curlewis JD J Neuroendocrinol; 1994 Oct; 6(5):549-55. PubMed ID: 7827625 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658 [TBL] [Abstract][Full Text] [Related]
11. Antagonist of pituitary adenylate cyclase activating polypeptide suppresses prolactin secretion without changing the activity of dopamine neurons in lactating rats. Tohei A; Matsuzaki M; Kogo H Neuroendocrinology; 2001 Jan; 73(1):68-74. PubMed ID: 11174019 [TBL] [Abstract][Full Text] [Related]
12. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L; Ahrén B; Edgren G; Degerman E Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088 [TBL] [Abstract][Full Text] [Related]
13. Central galanin stimulates pituitary prolactin secretion in rats: possible involvement of hypothalamic vasoactive intestinal polypeptide. Koshiyama H; Kato Y; Inoue T; Murakami Y; Ishikawa Y; Yanaihara N; Imura H Neurosci Lett; 1987 Mar; 75(1):49-54. PubMed ID: 2437498 [TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidence. Schomerus C; Maronde E; Laedtke E; Korf HW Cell Tissue Res; 1996 Dec; 286(3):305-13. PubMed ID: 8929333 [TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells. Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043 [TBL] [Abstract][Full Text] [Related]
16. An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats. Wheeler S; Eardley JE; McNulty KF; Sutcliffe CP; Morrison JD Exp Physiol; 1997 Jul; 82(4):729-47. PubMed ID: 9257115 [TBL] [Abstract][Full Text] [Related]
17. A novel hypothalamic peptide, pituitary adenylate cyclase-activating peptide, regulates the function of rat granulosa cells in vitro. Heindel JJ; Sneeden J; Powell CJ; Davis B; Culler MD Biol Reprod; 1996 Mar; 54(3):523-30. PubMed ID: 8835372 [TBL] [Abstract][Full Text] [Related]
18. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of the rat. Alonso RM; Rodríguez AM; García LJ; López MA; Calvo JJ Pancreas; 1994 Jan; 9(1):123-8. PubMed ID: 7509062 [TBL] [Abstract][Full Text] [Related]
19. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle. Ekblad E; Sundler F Eur J Pharmacol; 1997 Sep; 334(1):61-6. PubMed ID: 9346329 [TBL] [Abstract][Full Text] [Related]